RichardsonL.LuchsingerV. (2005) ‘Direct-to-customer advertising of pharmaceutical products: Issue analysis and direct-to-consumer promotion’, Journal of American Academy of Business, 7(2), 100–104.
2.
PersaudA. (2005) ‘Enhancing synergistic innovative capability in multinational corporations: An empirical investigation’, Journal of Product Innovation Management, 22(5), 412–429.
3.
CorstjensM.DemeireE.HorowitzI. (2005) ‘New-product success in the pharmaceutical industry: How many bites at the cherry?’, Economics of Innovation & New Technology, 14(4), 319–331.
4.
BuckleyJ.TuamaS. (2005) ‘International pricing and distribution of therapeutic pharmaceuticals: An ethical minefield’, Business Ethics: A European Review, 14(2), 127–141.
5.
DawkinsC. (2005) ‘First to market: Issue management pacesetters and the pharmaceutical industry response to AIDS in Africa’, Business and Society, 44(3), 244–282.
6.
BowerD.J. (2005) ‘From the “rhetoric of hope” to the “patient-active paradigm” - strategic positioning of pharmaceutical and biotechnology companies’, Technology Analysis and Strategic Management, 17(2), 183–204.
